The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Open accessAbstract
Fibrillar amyloid-beta (Aβ) is found in the brains of many cognitively normal older people. Whether or not this reflects a predisposition to Alzheimer's disease (AD) is unknown. We used Pittsburgh Compound B (PiB) PET to characterize the relationship between fibrillar Aβ burden and this predisposition in cognitively normal older people at 3 mean levels of genetic risk for AD. Dynamic PiB PET scans, the Logan method, statistical parametric mapping, and automatically labeled regions of interest (ROIs) were used to characterize and compare cerebral-to-cerebellar PIB distribution volume ratios, reflecting fibrillar Aβ burden, in 28 cognitively normal persons (mean age, 64 years) with a reported family history of AD and 2 copies, 1 copy, and no copies of the apolipoprotein E (APOE) ε4 allele. The 8 ε4 homozygotes, 8 heterozygotes, and 12 noncarriers did not differ significantly in terms of age, sex, or cognitive scores. Fibrillar Aβ was significantly associated with APOE ε4 carrier status and ε4 gene dose in AD-affected mean cortical, frontal, temporal, posterior cingulate-precuneus, parietal, and basal ganglia ROIs, and was highest in an additional homozygote who had recently developed mild cognitive impairment. These findings suggest that fibrillar Aβ burden in cognitively normal older people is associated with APOE ε4 gene dose, the major genetic risk factor for AD. Additional studies are needed to track fibrillar Aβ accumulation in persons with different kinds and levels of AD risk; to determine the extent to which fibrillar Aβ, alone or in combination with other biomarkers and risk factors, predicts rates of cognitive decline and conversion to clinical AD; and to establish the role of fibrillar Aβ imaging in primary prevention trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Crossing a transgenic mouse model of AD that has high levels of human Aβ in the brain with human APOE targeted replacement mice demonstrated age-dependent and APOE isoform-dependent (E4>>E3>E2) Aβ deposition and amyloid burden in the brain in a manner that recapitulates the human condition observed in pre-symptomatic elderly APOE4 carriers as well as AD patients.18–21”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the amyloid deposition spreads, and the disease pathogenesis progressively involves a broad region of the brain”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The association of the APOE4 isoform with amyloid deposition has been well established in human studies, where APOE4 carriers exhibit higher A β plaque burden and earlier onset of amyloid positivity compared with non-carriers 35 -37 .”
From APOE2 attenuates APOE4-associated amyloid pathology and related toxicity in a mouse model of Alzheimer’s disease (2026) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APOE status has been found to modulate the onset of extracellular amyloid plaque deposition, one of the key pathognomonic features of the disease (6, 7).”
From Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, the APOE ε4 allele increases brain amyloid burden assessed by PIB-PET imaging in a gene dose-dependent manner (6).”
From Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) · cites this paper as [6]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APOE isoform-dependent amyloid deposition has been consistently observed in humans and Aβ depositing mouse models (Holtzman et al., 2000; Bales et al., 2009; Reiman et al., 2009; Morris et al., 2010).”
From Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis (2011) · cites this paper as Reiman et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ε4 allele increased brain amyloid burden in a dose-dependent manner in normal elderly individuals and in mild cognitive impairment patients [93,94].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [93]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This finding has now been confirmed more directly in a study that showed cognitively normal subjects had an ε4 dose-dependent increase in fibrillar Aβ burden in brain as detected with an amyloid imaging agent (Reiman et al., 2009).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Reiman et al., 2009
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This possibility has remained unaddressed, because case–control studies without neuropathological or biomarker assessments of AD may have underestimated the impact of APOE genotypes on Alzheimer’s dementia ORs due to the confounding effects of APOE genotypes on the percentages of neuropathologically misclassified cases and controls8–10.”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [9]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Due to the prioritized ascertainment of those cases who met the clinical and neuropathological criteria for Alzheimer’s dementia and those unimpaired controls without AD, the number of misclassified cases and controls available through the AD Genetics Consortium12 is much smaller than our estimated number of neuropathologically misclassified cases and controls8–11, limiting our ability to clarify”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [9]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In a previous autopsy study, we found that 25% of persons with the clinical diagnosis of mild-to-moderate Alzheimer’s dementia lacked at least moderately frequent neuritic plaques, one of the cardinal features of AD, including 37% of APOE4 non-carriers and 13% of carriers, findings that are consistent with those in living patients9,10.”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [9]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Self-citationStrittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · cited 1×
“The APOE 4 allele is associated with increased cerebral and vascular A deposition in AD (25), and the ApoE E4 isoform is associated with increased A binding, fibrillization, and cerebral and vascular A deposition (13, 26), as well as with decreased ApoE-mediated A clearance and degradation (27–29).”
BackgroundRestriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Cited by
Sorted by citations
Items 301–400 of 787
An investigation of PreMCI: Subtypes and longitudinal outcomes
Loewenstein, D., Greig, M. T., Schinka, J. A., Barker, W., Shen, Q., Potter, E. L., Raj, A., Brooks, L., Varón, D., Schoenberg, M. R., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.03.002 · Cited by 55
FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?
Mosconi, L., & McHugh, P. F. (2011) · PubMed · Cited by 54
Early Detection of Alzheimer’s Disease with PET Imaging
Berti, V., Osorio, R. S., Mosconi, L., Li, Y., Santi, S. D., & de Leon, M. J. (2010) · Neurodegenerative Diseases · doi:10.1159/000289222 · Cited by 53
Lista, S., Molinuevo, J. L., Cavedo, E., Rami, L., Amouyel, P., Teipel, S. J., Garaci, F., Toschi, N., Habert, M.-O., Blennow, K., et al. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150202 · Cited by 53
Subjective Memory Complaints in APOE ɛ 4 Carriers are Associated with High Amyloid-β Burden
Zwan, M. D., Villemagne, V. L., Doré, V., Buckley, R. F., Bourgeat, P., Veljanoski, R., Salvado, O., Williams, R., Margison, L., Rembach, A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150446 · Cited by 55
Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease
Bales, K. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.005 · Cited by 58
Vance, J. M., Farrer, L. A., Huang, Y., Cruchaga, C., Hyman, B. T., Pericak‐Vance, M. A., Goate, A. M., Greicius, M. D., Griswold, A. J., Haines, J. L., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26864 · Cited by 52
Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD
Mosconi, L., Murray, J., Tsui, W. H., Li, Y., Spector, N. C., Goldowsky, A. M., Williams, S., Osorio, R. S., McHugh, P. F., Glodzik, L., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000181 · Cited by 51
Bangen, K. J., Initiative, F. T. A. D. N., Clark, A. L., Werhane, M., Edmonds, E. C., Nation, D. A., Evangelista, N., Libon, D. J., Bondi, M. W., & Delano-Wood, L. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150900 · Cited by 51
Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease
Berti, V., Polito, C., Lombardi, G., Ferrari, C., Sorbi, S., & Pupi, A. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2477-1 · Cited by 54
Neuroimaging in aging and neurologic diseases
Risacher, S. L., & Saykin, A. J. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00012-1 · Cited by 56
Initiative, A. D. N., Liu, Y., Tan, L., Wang, H.-F., Liu, Y., Hao, X., Tan, C., Jiang, T., Liu, B., Zhang, D., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9388-7 · Cited by 54
Wirth, M., Binette, A. P., Brunecker, P., Köbe, T., Witte, A. V., & Flöel, A. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16641128 · Cited by 58
Sacuiu, S. F. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00008-2 · Cited by 57
Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy
Ramirez, L. M., Goukasian, N., Porat, S., Hwang, K., Eastman, J. A., Hurtz, S., Wang, B., Vang, N., Sears, R., Klein, E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.037 · Cited by 51
Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
Choi, H. J., Byun, M. S., Yi, D., Sohn, B. K., Lee, J. H., Lee, D. Y., Kim, Y. K., & Lee, D. Y. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0291-5 · Cited by 51
Molecular Imaging Approaches in Dementia
Villemagne, V. L., Barkhof, F., Garibotto, V., Landau, S. M., Nordberg, A. K., & van Berckel, B. N. M. (2021) · Radiology · doi:10.1148/radiol.2020200028 · Cited by 56
Stage, E., Duran, T., Risacher, S. L., Goukasian, N., Do, T. M., West, J. D., Wilhalme, H. M., Nho, K. T., Phillips, M. L., Elashoff, D. A., et al. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.12.003 · Cited by 51
Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition
Burnham, S. C., Laws, S. M., Budgeon, C. A., Doré, V., Porter, T., Bourgeat, P., Buckley, R. F., Murray, K., Ellis, K. A., Turlach, B. A., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.001 · Cited by 55
Sex differences in the genetic architecture of Alzheimer’s disease
Dumitrescu, L., Mayeda, E. R., Sharman, K., Moore, A. M., & Hohman, T. J. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-0157-1 · Cited by 48
Murphy, K. R., Landau, S. M., Choudhury, K. R., Hostage, C. A., Shpanskaya, K. S., Sair, H. I., Petrella, J. R., Wong, T. Z., & Doraiswamy, P. M. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.04.048 · Cited by 50
Association of B cell profile and receptor repertoire with the progression of Alzheimer’s disease
Park, J.-C., Noh, J., Jang, S., Kim, K. H., Choi, H., Lee, D., Kim, J., Chung, J., Lee, D. Y., Lee, Y., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111391 · Cited by 48
Nichols, L. M., Masdeu, J. C., Mattay, V. S., Kohn, P. D., Emery, M. R., Sambataro, F., Kolachana, B. S., Elvevåg, B., Kippenhan, S., Weinberger, D. R., et al. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1893 · Cited by 52
Neuroimaging biomarkers in Alzheimer’s disease and other dementias
Villemagne, V. L., & Chételat, G. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.004 · Cited by 55
Beach, T. G., Thal, D. R., Zanette, M., Smith, A. P. L., & Buckley, C. J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150732 · Cited by 48
Phagocytosis of Apoptotic Cells Is Specifically Upregulated in ApoE4 Expressing Microglia in vitro
Muth, C., Hartmann, A., Falla, D. S., Glatzel, M., & Krasemann, S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00181 · Cited by 47
Advances in Brain Amyloid Imaging
Krishnadas, N., Villemagne, V. L., Doré, V., & Rowe, C. C. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.005 · Cited by 48
Gordon, B. A., Zacks, J. M., Blazey, T., Benzinger, T. L. S., Morris, J. C., Fagan, A. M., Holtzman, D. M., & Balota, D. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.01.019 · Cited by 49
Raulin, A.-C., Kraft, L., Al-Hilaly, Y. K., Xue, W.-F., McGeehan, J. E., Atack, J. R., & Serpell, L. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.019 · Cited by 47
Despite its role in assembly, methionine 35 is not necessary for amyloid β‐protein toxicity
Maiti, P., Lomakin, A., Benedek, G. B., & Bitan, G. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06692.x · Cited by 46
APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years
Taylor, J. L., Scanlon, B. K., Farrell, M. E., Hernandez, B., Adamson, M. M., Ashford, J. W., Noda, A. M., Murphy, G. M., & Weiner, M. W. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.011 · Cited by 48
Neuroimaging of Alzheimer’s disease: focus on amyloid and tau PET
Matsuda, H., Shigemoto, Y., & Sato, N. (2019) · Japanese Journal of Radiology · doi:10.1007/s11604-019-00867-7 · Cited by 50
Tosun, D., Demir, Z., Veitch, D. P., Weintraub, D. A., Aisen, P. S. S., Jack, C. R., Jagust, W., Petersen, R. C., Saykin, A. J., Shaw, L. M. J., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12480 · Cited by 46
Kim, S. H., Lee, P., Oh, K. T., Byun, M. S., Yi, D., Lee, J. H., Kim, Y. K., Ye, B. S., Yun, M., Lee, D. Y., et al. (2021) · EJNMMI Research · doi:10.1186/s13550-021-00798-3 · Cited by 45
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status
Swaminathan, S., Risacher, S. L., Yoder, K. K., West, J. D., Shen, L., Kim, S., Inlow, M. H., Foroud, T., Jagust, W., Koeppe, R. A., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.007 · Cited by 45
Self-citationWalters, M., Sterling, J. L., Quinn, C. G., Ganzer, C. A., Osorio, R. S., Andrews, R. D., Matthews, D. C., Vallabhajosula, S., de Leon, M. J., Isaacson, R., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023664 · Cited by 45
Dong, Q., Zhang, W., Wu, J., Li, B., Schron, E. H., McMahon, T., Shi, J., Gutman, B. A., Chen, K., Baxter, L. C., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101744 · Cited by 44
Self-citationKoriath, C., Lashley, T., Taylor, W., Druyeh, R., Dimitriadis, A., Denning, N., Williams, J. H., Warren, J. D., Fox, N. C., Schott, J. M., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.01.010 · Cited by 48
Kim, J. W., Byun, M. S., Yi, D., Lee, J. H., Ko, K., Jeon, S. Y., Sohn, B. K., Lee, J., Kim, Y. K., Shin, S. A., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003022 · Cited by 48
Mormino, E. C. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9267-4 · Cited by 44
Han, S., Park, J., Byun, M. S., Yi, D., Lee, J. H., Lee, D. Y., & Mook‐Jung, I. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.001 · Cited by 44
Malek‐Ahmadi, M. H., Su, Y., Ghisays, V., Luo, J., Devadas, V., Chen, Y., Lee, W., Protas, H. D., Chen, K., Zetterberg, H., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01221-w · Cited by 43
Self-citationHippocampal synaptic and neural network deficits in young mice carrying the humanAPOE 4 gene
Sun, G., He, Y., Ma, X. K., Li, S., Chen, D., Gao, M., Qiu, S., Yin, J., Shi, J., & Wu, J. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12720 · Cited by 42
Shokouhi, S., Mckay, J. W., Baker, S. L., Kang, H., Brill, A. B., Gwirtsman, H. E., Riddle, W. R., Claassen, D. O., Rogers, B. P., & Initiative, A. D. N. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0172-3 · Cited by 42
A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer’s Disease
Khan, W., Initiative, A. D. N., Giampietro, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., Flor, H., Frouin, V., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161097 · Cited by 41
A machine learning approach to screen for preclinical Alzheimer's disease
Gaubert, S., Houot, M., Raimondo, F., Ansart, M., Corsi, M., Naccache, L., Sitt, J. D., Habert, M., Dubois, B., Fallani, F. D. V., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.024 · Cited by 43
Serum Uric Acid, Alzheimer-Related Brain Changes, and Cognitive Impairment
Kim, J. W., Byun, M. S., Yi, D., Lee, J. H., Jeon, S. Y., Ko, K., Jung, G., Lee, H. N., Lee, J., Sohn, C., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00160 · Cited by 41
The Role of Diffusion Tensor Imaging in the Study of Cognitive Aging
Carmichael, O. T., & Lockhart, S. N. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_176 · Cited by 46
Yi, D., Lee, D. Y., Sohn, B. K., Choe, Y. M., Seo, E. H., Byun, M. S., & Woo, J. I. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.12.173 · Cited by 42
Cavedo, E., Lista, S., Rojkova, K., Chiesa, P. A., Houot, M., Brueggen, K., Blautzik, J., Bokde, A. L. W., Dubois, B., Barkhof, F., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.048 · Cited by 40
Operto, G., Molinuevo, J. L., Cacciaglia, R., Falcon, C., Brugulat-Serrat, A., Suárez-Calvet, M., Grau-Rivera, O., Bargalló, N., Morán, S., Esteller, M., et al. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101983 · Cited by 40
A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives
Li, L., Yu, X., Sheng, C., Jiang, X., Zhang, Q., Han, Y., & Jiang, J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00315-z · Cited by 40
Yi, D., Choe, Y. M., Byun, M. S., Sohn, B. K., Seo, E. H., Han, J., Park, J., Woo, J. I., & Lee, D. Y. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00015 · Cited by 40
Kukolja, J., Thiel, C. M., Eggermann, T., Zerres, K., & Fink, G. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.044 · Cited by 40
Abnormalities of plasma cytokines and spleen in senile APP/PS1/Tau transgenic mouse model
Yang, S., Kim, J., Lee, M. J., & Kim, Y. S. (2015) · Scientific Reports · doi:10.1038/srep15703 · Cited by 40
Alzheimer Lesions in the Autopsied Brains of People 30 to 50 Years of Age
Pletniková, O., Rudow, G. L., Hyde, T. M., Kleinman, J. E., Ali, S. Z., Bharadwaj, R. A., Gangadeen, S., Crain, B. J., Fowler, D. R., Rubio, A. I., et al. (2015) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000071 · Cited by 40
Jeon, S. Y., Byun, M. S., Yi, D., Lee, J. H., Choe, Y. M., Ko, K., Sohn, B. K., Choi, H. J., Lee, J., & Lee, D. Y. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.11.001 · Cited by 42
Chen, K., Ayutyanont, N., Langbaum, J. B. S., Fleisher, A., Reschke, C., Lee, W., Liu, X., Alexander, G. E., Bandy, D., Caselli, R. J., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.005 · Cited by 39
Self-citationMetals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology
Wong, B. X. W., Hung, Y. H., Bush, A. I., & Duce, J. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00091 · Cited by 41
The Effects of Soluble A.β Oligomers on Neurodegeneration in Alzheimer's Disease
Brouillette, J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990498 · Cited by 39
Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
Wısnıewskı, T., & Boutajangout, A. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0236-2 · Cited by 39
Pettigrew, C., Soldan, A., Moghekar, A., Wang, M.-C., Gross, A. L., O’Brien, R., & Albert, M. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2015.09.024 · Cited by 38
Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
Zhang, L., Xia, Y., & Gui, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1199434 · Cited by 41
Wang, X., Wang, J., He, Y., Li, H., Yuan, H., Evans, A. C., Yu, X., Yong He, A., & Wang, H. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142556 · Cited by 38
Wirth, M., Bejanin, A., Joie, R. L., Arenaza‐Urquijo, E. M., Gonneaud, J., Landeau, B., Perrotin, A., Mézenge, F., Sayette, V. D. L., Desgranges, B., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.023 · Cited by 40
Inflammation as a Possible Link Between Dyslipidemia and Alzheimer’s Disease
Oliveira, B. C. D. L., Bellozi, P. M. Q., Reis, H. J., & de Oliveira, A. C. P. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.012 · Cited by 39
Amyloid-plaque imaging in early and differential diagnosis of dementia
Drzezga, A. E. (2010) · Annals of Nuclear Medicine · doi:10.1007/s12149-009-0330-9 · Cited by 37
More than just risk for Alzheimer’s disease: APOE ε4's impact on the aging brain
Palmer, J. M., Huentelman, M. J., & Ryan, L. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.06.003 · Cited by 39
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia
Ingannato, A., Bagnoli, S., Mazzeo, S., Giacomucci, G., Bessi, V., Ferrari, C., Sorbi, S., & Nacmias, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1375302 · Cited by 41
What have Novel Imaging Techniques Revealed About Metabolism in the Aging Brain?
Lin, A., & Rothman, D. L. (2014) · Future Neurology · doi:10.2217/fnl.14.13 · Cited by 37
Mecca, A. P., Barcelos, N. M., Wang, S., Brück, A., Nabulsi, N., Planeta‐Wilson, B., Nadelmann, J. B., Benincasa, A. L., Ropchan, J. R., Huang, Y. H., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.027 · Cited by 40
Ghisays, V., Goradia, D. D., Protas, H. D., Bauer, R. J., III, Devadas, V., Tariot, P. N., Lowe, V. J., Knopman, D. S., Petersen, R. C., Jack, C. R., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.08.195 · Cited by 35
Self-citationInteractive rather than independent effect of APOE and sex potentiates tau deposition in women
Wang, Y., Pascoal, T. A., Therriault, J., Kang, M. S., Benedet, A. L., Savard, M., Tissot, C., Lussier, F. Z., Arias, J. F., Mathotaarachchi, S. S., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab126 · Cited by 37
Amyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions
Rowley, P. A., Samsonov, A. A., Betthauser, T. J., Pirasteh, A., Johnson, S. C., & Eisenmenger, L. B. (2020) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2020.08.011 · Cited by 40
APOE and immunity: Research highlights
Kloske, C. M., Barnum, C. J., Batista, A. F., Bradshaw, E. M., Brickman, A. M., Bu, G., Dennison, J. L., Gearon, M. D., Goate, A., Haass, C., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13020 · Cited by 38
Self-citationPopp, J., Lewczuk, P., Frommann, I., Kölsch, H., Kornhuber, J., Maier, W., & Jessen, F. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100561 · Cited by 36
Sojkova, J., & Resnick, S. M. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745375 · Cited by 36
Tentolouris-Piperas, V., Ryan, N. S., Thomas, D. L., & Kinnunen, K. M. (2016) · Brain Research · doi:10.1016/j.brainres.2016.11.011 · Cited by 38
The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques
Li, T., & Wahlund, L. (2011) · Acta Radiologica · doi:10.1258/ar.2010.100053 · Cited by 33
Kagerer, S. M., Bergen, J. M. G. V., Li, X., Quevenco, F. C., Gietl, A. F., Studer, S. T., Treyer, V., Meyer, R., Kaufmann, P. A., Nitsch, R. M., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12002 · Cited by 37
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
Dincer, A., Chen, C. D., McKay, N. S., Koenig, L. N., McCullough, A. A., Flores, S. E., Keefe, S., Schultz, S. A., Feldman, R. L., Joseph‐Mathurin, N., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl7646 · Cited by 34
Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype
Lane, R. M., & He, Y. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.005 · Cited by 35
Paternicò, D., Galluzzi, S., Drago, V., Bocchio‐Chiavetto, L., Zanardini, R., Pedrini, L., Baronio, M., Amicucci, G., & Frisoni, G. B. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.10.003 · Cited by 34
Hippocampus-related cognitive impairments in young apoE4 targeted replacement mice
Salomon-Zimri, S., Boehm-Cagan, A., Liraz, O., & Michaelson, D. M. (2013) · Neurodegenerative Diseases · doi:10.1159/000354777 · Cited by 34
The prognostic value of amyloid imaging
Gelosa, G., & Brooks, D. J. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2108-x · Cited by 35
Physical Frailty and Amyloid-β Deposits in the Brains of Older Adults with Cognitive Frailty
Yoon, D. H., Lee, J., Shin, S. A., Kim, Y., & Song, W. J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7070169 · Cited by 34
Cognitive reserve proxies, Alzheimer pathologies, and cognition
Ko, K., Yi, D., Byun, M. S., Lee, J. H., Jeon, S. Y., Kim, W. J., Byeon, G., Sung, K., Han, D., Lee, Y., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.10.005 · Cited by 34
Deep learning-Based 3D inpainting of brain MR images
Kang, S. K., Shin, S. A., Seo, S., Byun, M. S., Lee, D. Y., Kim, Y. K., Lee, D. S., & Lee, J. S. (2021) · Scientific Reports · doi:10.1038/s41598-020-80930-w · Cited by 34
Serum zinc levels and in vivo beta-amyloid deposition in the human brain
Kim, J. W., Byun, M. S., Yi, D., Lee, J. H., Jung, G., Jung, G., Lee, J.-Y., Kang, K. M., Sohn, C., Lee, D. Y., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00931-3 · Cited by 35
Relationship of Amyloid-Beta Burden With Age-At-Onset in Alzheimer Disease
Choo, I. H., Lee, D. Y., Kim, J. W., Seo, E. H., Lee, D. S., Kim, Y. K., Kim, S. G., Park, S. Y., Woo, J. I., & Yoon, E. J. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318202bf3a · Cited by 35
Cholesterol Balance in Prion Diseases and Alzheimer’s Disease
Hannaoui, S., Shim, S. Y., Cheng, Y. C., Corda, E., & Gilch, S. (2014) · Viruses · doi:10.3390/v6114505 · Cited by 36
Apolipoprotein E secreted by astrocytes forms antiparallel dimers in discoidal lipoproteins
Strickland, M. R., Rau, M. J., Summers, B., Basore, K., Wulf, J., Jiang, H., Chen, Y., Ulrich, J. D., Randolph, G. J., Zhang, R., et al. (2024) · Neuron · doi:10.1016/j.neuron.2023.12.018 · Cited by 28
APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses
Friday, C. M., Stephens, I. O., Smith, C. T., Lee, S., Satish, D., Devanney, N. A., Cohen, S., Morganti, J. M., Gordon, S. M., & Johnson, L. A. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106983 · Cited by 33
Longitudinal change in working memory as a function of APOE genotype in midlife and old age
Greenwood, P. M., Espeseth, T., Lin, M., Reinvang, I., & Parasuraman, R. (2014) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12123 · Cited by 37
Multiparity, Brain Atrophy, and Cognitive Decline
Jung, J. H., Lee, G. W., Lee, J. H., Byun, M. S., Yi, D., Jeon, S. Y., Jung, G., Joung, H., Shin, S. A., Kim, Y. K., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00159 · Cited by 33
Gunnarsson, M. D., Lindau, M. P., Wall, A., Blennow, K., Darreh‐Shori, T., Basu, S., Nordberg, A. K., Larsson, A., Lannfelt, L., Basun, H., et al. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000281832 · Cited by 33
Human APOE genotype affects intraneuronal A 1-42 accumulation in a lentiviral gene transfer model
Zhao, W., Dumanis, S. B., Tamboli, I. Y., Rodriguez, G. A., Jo LaDu, M., Moussa, C. E. H., & William Rebeck, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt525 · Cited by 32
Apolipoprotein E ε4-related thickening of the cerebral cortex modulates selective attention
Espeseth, T., Westlye, L. T., Walhovd, K. B., Fjell, A. M., Endestad, T., Rootwelt, H., & Reinvang, I. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.027 · Cited by 32
Chen, C.-J., Chen, C.-C., Wu, D., Chi, N., Chen, P.-C., Liao, Y., Chiu, H., & Hu, C. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3369 · Cited by 34
Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers
Chételat, G., & Fouquet, M. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.025 · Cited by 32
Metadata
- Authors
- Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., Alexander, G. E., Klunk, W. E., Mathis, C. A., Price, J. C., Aizenstein, H. J., DeKosky, S. T., & Caselli, R. J.
- Affiliations
- Translational Genomics Research Institute (US)
- Banner - University Medical Center Phoenix (US)
- University of Arizona (US)
- Departments of iPsychiatry,
- University of Pittsburgh (US)
- Mayo Clinic in Arizona (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-21
- Volume
- 106
- Issue
- 16
- Pages
- 6820-6825
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2665196
- OpenAlex
- W2171346860
- Semantic Scholar
- 50d5adab23ba1a800626a6f613f94a2c667b07e4
- Cited by
- 785
- References
- 44
- Citations by year
- 2026: 15 · 2025: 26 · 2024: 34 · 2023: 36 · 2022: 36 · 2021: 45 · 2020: 44 · 2019: 39 · 2018: 34 · 2017: 34 · 2016: 40 · 2015: 50 · 2014: 66 · 2013: 61 · 2012: 65
- FWCI
- 45.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- McKnight Foundation
- National Institute on Aging (R01AG025526, R01AG018402, P01AG025204, RF1AG025516, P50AG005133, R01AG031581, P30AG019610, R37AG025516)
- National Institute of Mental Health (R01MH070729, R01MH057899)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- fibrillar amyloid-beta, Alzheimer's disease, APOE ε4, genetic risk, cognitively normal older adults, Pittsburgh compound B PET, family history of Alzheimer's disease, mild cognitive impairment, primary prevention
- MeSH terms
- Aged, Alzheimer Disease, Brain Mapping, Cognition, Heterozygote, Homozygote, Humans, Magnetic Resonance Imaging, Middle Aged, Neuropsychological Tests, Amyloid beta-Peptides, Gene Dosage, Genetic Predisposition to Disease, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
